Human CD45+ immune cell and CD33+ myeloid cell frequencies were maintained in peripheral blood independent of tumor growth, with higher myeloid counts in HIS-NOG-EXL as previously described for non-tumor-bearing mice (Figure 5B, Supplementary Figure 5B). Here, CD33 is linked to neoplasm.